Ireland
--:--IST
Latest
Clinical Trials in France / NCT07334314
Recruiting Observational

Olfactive Detection of Urothelial Carcinoma by Sniffer Dogs

NCT07334314 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2025-06-20
Last updated
2026-01-12

Condition(s) studied

Urothelial Carcinoma

Investigational drug(s) / intervention(s)

olfactory detection by dogs

olfactory detection by dogs: olfactory detection of urothelial carcinoma of the bladder in a urine sample by dogs

Study summary

The aim of this study is to estimate the sensitivity of olfactory detection of urothelial carcinomas of the bladder in urine samples by assistance dogs trained in this practice.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adult (\> 18 years old) * Subject scheduled for any endourological surgery involving an initial cystoscopy, the most common of which are: transurethral resection of the bladder, transurethral resection of the prostate, internal optical urethrotomy, bladder lithoclast, ureteral stent replacement, ureteroscopy, etc. (non-exhaustive list) * Subjects for whom a urine sample (for bacteriological or cytological testing) is planned as part of routine practice in the month prior to the procedure * Subjects affiliated with a health insurance plan or beneficiaries of such a plan Exclusion Criteria: * Absence of signed informed consent / inability to provide the subject with informed information (emergency situations, difficulties in understanding the subject, etc.) * Patient under guardianship, conservatorship, or judicial protection * History of cancer other than urothelial bladder carcinoma, unless in complete remission for \> 5 years * Pregnant or breastfeeding women

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Hôpitaux Civils de Colmar Colmar France Recruiting
Hôpitaux Universitaires de Strasbourg Strasbourg France Recruiting

More University Hospital, Strasbourg, France trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07334314 on ClinicalTrials.gov ↗ ← All trials in France